S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ORIC Oric Pharmaceuticals Inc

8.52

0.09 (1.07%)

Dec 13 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals Inc News

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Monday 25 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Monday 4 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 9 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 4 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 6 September 2024 (3 months ago) • GlobeNewswire Inc.

More Oric Pharmaceuticals Inc News Articles

Fundo De Investimento Im...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions